期刊文献+

辛伐他汀对冠心病心绞痛甲襞微循环的影响

下载PDF
导出
摘要 目的:应用辛伐他汀治疗冠心病心绞痛68例,并于治疗前后对患者甲襞微循环进行对比观察。方法:68例患者均口服辛伐他汀片20 mg,每晚顿服,4周为1疗程,服药前与4周后分别检查甲襞微循环、常规12导联心电图、血糖、血脂、血压、心率、肝功能等。结果:68例患者在经过4周治疗后,劳力型心绞痛和自发型心绞痛者症状改善总有效率分别为88.6%,81.2%。结论:辛伐他汀对伴有高血压、高血脂的冠心病患者有肯定疗效。
机构地区 湖北省鄂钢医院
出处 《中国民康医学》 2007年第9期375-376,共2页 Medical Journal of Chinese People’s Health
  • 引文网络
  • 相关文献

参考文献3

  • 1鄢华,高炜.他汀类药物作用和作用机制的新认识[J].临床内科杂志,2006,23(1):5-7. 被引量:23
  • 2-.心血管病流行病学及人群防治汇报讨论会[J].中华心血管病杂志,1979,7(2):81-81.
  • 3Spsito AC,Chapman MJ.Statin therapy in acute cornary syndromes[J].Arterioscler.Thromb.Vasc.Biol,2002,22:1524-1534.

二级参考文献15

  • 1Stepp DW, Ou J, Ackerman AW, et al. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol,2002 ;283 :H750-759.
  • 2Ou J,Ou Z,Jones DW,et al. L-4F,an apolipoprotein A-1 mimetic,dramatically improves vasodilation in hypercholestemlemia and sickle cell disease. Circulation ,2003,107:2337-2341.
  • 3Mason RP,Walter MF,Jacob RF. Effects of HMG-CoA reductase inhibitors on endothelial function : role of microdomains and oxidative stress.Circulation,2004,109 ( Suppl 1 ) : Ⅱ34-41.
  • 4Wassmann S, Laufs U, Stamenkovic D, et al. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation,2002,105:2053-2091.
  • 5Feron O, Dessy C, Desager JP,et al. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation, 2001,103 : 113-118.
  • 6Walter MF, Jacob RF,Jeffers B, et al. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease:a longitudinal analysis of the PREVENT study.J Am Coll Cardiol ,2004 ,44 :1996-2002.
  • 7Wassmann S, Laufs U, Muller K, et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol,2002,22:300-305.
  • 8Van Wissen S,Trip MD,Smilde TJ,et al. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. Atherosclerosis ,2002,165 : 361-366.
  • 9Wiklund O, Mattsson-Hulten L, Hurt-Camejo E, et al. Effects of simvastatin and atorvastatin on inflammation markers in plasma. J Intern Med 2002,251:338-347.
  • 10Nissen SE,Tuzcu EM, Schoenhagen P, et al. for the REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA ,2004,291 : 1071-1080.

共引文献25

;
使用帮助 返回顶部